Literature DB >> 16234535

Is TGFBR1*6A really associated with increased risk of cancer?

Hong-Tao Zhang, Jun Zhao, Shi-Ying Zheng, Xiao-Feng Chen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16234535     DOI： 10.1200/JCO.2005.02.9108

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  16 in total

Review 1.  Recent advances in breast cancer genetics.

Authors:  Boris Pasche
Journal:  Cancer Treat Res       Date:  2008

2.  Debate about TGFBR1 and the susceptibility to colorectal cancer.

Authors:  Laura Valle
Journal:  World J Gastrointest Oncol       Date:  2012-01-15

3.  Aberrant methylation inactivates transforming growth factor Beta receptor I in head and neck squamous cell carcinoma.

Authors:  Teresita Muñoz-Antonia; Mariclara Torrellas-Ruiz; Jonathan Clavell; Linda A Mathews; Carlos A Muro-Cacho; Adriana Báez
Journal:  Int J Otolaryngol       Date:  2009-06-14

4.  Constitutively decreased TGFBR1 allelic expression is a common finding in colorectal cancer and is associated with three TGFBR1 SNPs.

Authors:  Boris Pasche; Kari B Wisinski; Maureen Sadim; Virginia Kaklamani; Michael J Pennison; Qinghua Zeng; Naresh Bellam; Jacquelyn Zimmerman; Nengjun Yi; Kui Zhang; John Baron; Daniel O Stram; M Geoffrey Hayes
Journal:  J Exp Clin Cancer Res       Date:  2010-05-25

5.  Somatic acquisition of TGFBR1*6A by epithelial and stromal cells during head and neck and colon cancer development.

Authors:  Yansong Bian; Thomas J Knobloch; Maureen Sadim; Virginia Kaklamani; Adekunle Raji; Guang-Yu Yang; Christopher M Weghorst; Boris Pasche
Journal:  Hum Mol Genet       Date:  2007-09-21       Impact factor: 6.150

6.  No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study.

Authors:  Timothy R Rebbeck; Antonis C Antoniou; Trinidad Caldes Llopis; Heli Nevanlinna; Kristiina Aittomäki; Jacques Simard; Amanda B Spurdle; Fergus J Couch; Lutecia H Mateus Pereira; Mark H Greene; Irene L Andrulis; Boris Pasche; Virginia Kaklamani; Ute Hamann; Csilla Szabo; Susan Peock; Margaret Cook; Patricia A Harrington; Alan Donaldson; Allison M Male; Carol Anne Gardiner; Helen Gregory; Lucy E Side; Anne C Robinson; Louise Emmerson; Ian Ellis; Jean-Philippe Peyrat; Joëlle Fournier; Philippe Vennin; Claude Adenis; Danièle Muller; Jean-Pierre Fricker; Michel Longy; Olga M Sinilnikova; Dominique Stoppa-Lyonnet; Rita K Schmutzler; Beatrix Versmold; Christoph Engel; Alfons Meindl; Karin Kast; Dieter Schaefer; Ursula G Froster; Georgia Chenevix-Trench; Douglas F Easton
Journal:  Breast Cancer Res Treat       Date:  2008-06-04       Impact factor: 4.872

Review 7.  TGF-β signaling in liver and gastrointestinal cancers.

Authors:  L H Katz; M Likhter; W Jogunoori; M Belkin; K Ohshiro; L Mishra
Journal:  Cancer Lett       Date:  2016-03-30       Impact factor: 8.679

Review 8.  TGF-beta signaling alterations and susceptibility to colorectal cancer.

Authors:  Yanfei Xu; Boris Pasche
Journal:  Hum Mol Genet       Date:  2007-04-15       Impact factor: 6.150

9.  TGFBR1*6A enhances the migration and invasion of MCF-7 breast cancer cells through RhoA activation.

Authors:  Diana S Rosman; Sharbani Phukan; Chiang-Ching Huang; Boris Pasche
Journal:  Cancer Res       Date:  2008-03-01       Impact factor: 12.701

10.  The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: a case-control study.

Authors:  Adela Castillejo; Trinidad Mata-Balaguer; Paola Montenegro; Enrique Ochoa; Rafael Lázaro; Ana Martínez-Cantó; María-Isabel Castillejo; Carla Guarinos; Víctor-Manuel Barberá; Carmen Guillén-Ponce; Alfredo Carrato; José-Luís Soto
Journal:  BMC Cancer       Date:  2009-06-18       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.